Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 1;28(4):279-289.
doi: 10.1097/MOT.0000000000001076. Epub 2023 May 23.

Immunosuppression in HIV-positive kidney transplant recipients

Bogdan Marian Sorohan  1   2 , Gener Ismail  1   3 , Nicolae Leca  4
Affiliations
Review

Immunosuppression in HIV-positive kidney transplant recipients

Bogdan Marian Sorohan et al. Curr Opin Organ Transplant. .

Abstract

Purpose of study: The purpose of this review is to provide the current state of immunosuppression therapy in kidney transplant recipients (KTR) with HIV and to discuss practical dilemmas to better understand and manage these patients.

Recent findings: Certain studies find higher rates of rejection, which raises the need to critically assess the approach to immunosuppression management in HIV-positive KTR. Induction immunosuppression is guided by transplant center-level preference rather than by the individual patient characteristics. Earlier recommendations expressed concerns about the use of induction immunosuppression, especially utilizing lymphocyte-depleting agents; however, updated guidelines based on newer data recommend that induction can be used in HIV-positive KTR, and the choice of agent be made according to immunological risk. Likewise, most studies point out success with using first-line maintenance immunosuppression including tacrolimus, mycophenolate, and steroids. In selected patients, belatacept appears to be a promising alternative to calcineurin inhibitors with some well established advantages. Early discontinuation of steroids in this population carries a high risk of rejection and should be avoided.

Summary: Immunosuppression management in HIV-positive KTR is complex and challenging, mainly because of the difficulty of maintaining a proper balance between rejection and infection. Interpretation and understanding of the current data towards a personalized approach of immunosuppression could improve management in HIV-positive KTR.

PubMed Disclaimer

References

    1. Abraham AG, Althoff KN, Jing Y, et al. North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis 2015; 60:941–949.
    1. Sawinski D, Forde KA, Locke JE, et al. Race but not hepatitis C co-infection affects survival of HIV(+) individuals on dialysis in contemporary practice. Kidney Int 2018; 93:706–715.
    1. Locke JE, Gustafson S, Mehta S, et al. Survival benefit of kidney transplantation in HIV-infected patients. Ann Surg 2017; 265:604–608.
    1. Tourret J, Guiguet M, Lassalle M, et al. Access to the waiting list and to kidney transplantation for people living with HIV: a national registry study. Am J Transplant 2019; 19:3345–3355.
    1. Lee DH, Boyle SM, Malat GE, et al. Barriers to listing for HIV-infected patients being evaluated for kidney transplantation. Transpl Infect Dis 2017; 19:e12777.